28152-73-0 Usage
Description
(3alpha,14beta,16alpha)-14,15-dihydro-14-hydroxyeburnamenine-14-carboxylic acid is a complex organic compound with a unique molecular structure. It is characterized by its specific stereochemistry, which is essential for its biological activities and potential applications.
Uses
Used in Pharmaceutical Industry:
(3alpha,14beta,16alpha)-14,15-dihydro-14-hydroxyeburnamenine-14-carboxylic acid is used as a pharmaceutical compound for its potential therapeutic effects. Its unique structure may allow it to interact with specific biological targets, making it a candidate for the development of new drugs.
Used in Research and Development:
(3alpha,14beta,16alpha)-14,15-dihydro-14-hydroxyeburnamenine-14-carboxylic acid is also used in research and development settings to study its chemical properties, potential interactions with biological systems, and to explore its possible applications in various fields, such as medicine, biotechnology, and materials science.
Used in Drug Delivery Systems:
Similar to gallotannin, (3alpha,14beta,16alpha)-14,15-dihydro-14-hydroxyeburnamenine-14-carboxylic acid could be employed in drug delivery systems to improve its bioavailability and therapeutic outcomes. The development of novel drug delivery systems, such as organic and metallic nanoparticles, could enhance the compound's efficacy against specific targets or diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 28152-73-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,8,1,5 and 2 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 28152-73:
(7*2)+(6*8)+(5*1)+(4*5)+(3*2)+(2*7)+(1*3)=110
110 % 10 = 0
So 28152-73-0 is a valid CAS Registry Number.
28152-73-0Relevant articles and documents
Preparation method of vinpocetine
-
Paragraph 0051-0054; 0058-0060; 0064-0066; 0070-0072; 0076, (2021/04/10)
The invention provides a preparation method of vinpocetine, which relates to the technical field of synthesis of medical intermediates, and comprises the following steps: (1) respectively feeding an ethanol solution of vincamine and an ethanol solution of sodium ethoxide into a premixer for premixing to form a mixed solution 1; (2) sending the mixed solution 1 obtained in the step (1) to a micro-channel module for complete reaction, and outputting the generated reaction solution to a transfer storage tank; (3) respectively feeding the solution and the mixed acid in the transfer storage tank obtained in the step (2) into a premixer for premixing to form a mixed solution 2; (4) sending the mixed solution 2 obtained in the step (3) to a micro-channel module for complete reaction, and outputting the generated reaction solution to a neutralization kettle; and (5) after the reaction is finished, carrying out post-treatment on the material in the neutralization kettle obtained in the step (4) to obtain the target product vinpocetine. The method has the advantages of high atom utilization rate, high selectivity, high yield and less solid waste, is beneficial to environmental protection, and is convenient for industrial production and utilization.
